PROSTATE CANCER - RECURRENT
Clinical trials for PROSTATE CANCER - RECURRENT explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER - RECURRENT trials appear
Sign up with your email to follow new studies for PROSTATE CANCER - RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized cell therapy trial offers new hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors will analyze a patient's tumor to select a specific target, then infuse specially engineered immune cells (CAR-NK cells) from a heal…
Matched conditions: PROSTATE CANCER - RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Five-Drug cocktail trial offers hope for advanced cancer patients
Disease control Recruiting nowThis early-stage trial is testing whether combining up to five existing oral medications is safe and can help control advanced solid tumors or prostate cancer that has returned after treatment. The study will first determine the safest combination of drugs, then see if that combi…
Matched conditions: PROSTATE CANCER - RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Advanced scan trial aims to pinpoint hidden prostate cancer
Diagnosis Recruiting nowThis study is testing a new type of PET/CT scan to see if it can accurately find prostate cancer that has come back after initial treatment. It will involve about 220 men who have rising PSA levels after surgery or radiation. The main goal is to see how well this new scan detects…
Matched conditions: PROSTATE CANCER - RECURRENT
Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated Mar 02, 2026 15:26 UTC
-
New hope for men suffering debilitating hot flashes from cancer treatment
Symptom relief Recruiting nowThis study is testing whether a medication called fezolinetant can safely reduce the frequency and severity of hot flashes in men with prostate cancer who are undergoing hormone-blocking therapy. Researchers will compare the drug to a placebo in 60 participants over 4 weeks to se…
Matched conditions: PROSTATE CANCER - RECURRENT
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Scientists track Body's defense system during prostate cancer treatment
Knowledge-focused Recruiting nowThis study aims to understand how the immune system changes in prostate cancer patients receiving brachytherapy (a type of internal radiation treatment). Researchers will track immune cells and other markers in blood and tissue samples taken before, during, and after treatment. T…
Matched conditions: PROSTATE CANCER - RECURRENT
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC